SOLV
Solventum Corporation
Price Chart
Latest Quote
$75.43
+0.87 (+1.17%)
Current Price
| Previous Close | $74.56 |
| Open | $75.24 |
| Day High | $75.77 |
| Day Low | $74.18 |
| Volume | 1,040,123 |
Stock Information
| Shares Outstanding | 173.17M |
| Total Debt | $5.29B |
| Cash Equivalents | $561.00M |
| Revenue | $8.26B |
| Net Income | $1.43B |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Market Cap | $13.06B |
| P/E Ratio | 9.23 |
| EPS (TTM) | $8.17 |
| Exchange | NYQ |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $17.99B |
| Sales | $8.26B |
| Income | $1.43B |
| Book/sh | $28.64 |
| Cash/sh | $3.24 |
| Employees | 21K |
Financial Ratios
| Quick Ratio | 0.52 |
| Current Ratio | 1.07 |
| Debt/Eq | 106.46 |
| EPS Growth TTM | -90.50% |
Returns & Margins
| ROA | 2.75% |
| ROE | 34.79% |
| Gross Margin | 53.65% |
| Operating Margin | 5.58% |
| Profit Margin | 17.33% |
Ownership
| Insider Ownership | 15.07% |
| Institutional Ownership | 76.54% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 10.70 |
| PEG | 1.22 |
| P/S | 1.58 |
| P/B | 2.63 |
Analyst Data
| Recommendation | buy |
| Target Price | $82.15 |
Technical Indicators
| SMA20 | $77.72 |
| SMA50 | $73.33 |
| SMA200 | $74.38 |
| RSI | 51.02 |
| ATR | 2.6653 |
| Shares Float | 147.07M |
| Short Float | 5.15% |
| Short Ratio | 3.38 |
| Volatility | 0.75 |
| Rel Volume | 1.01 |
Performance History
| Week | -4.78% |
| Month | +0.94% |
| Quarter | +12.35% |
| 6 Months | -6.40% |
| YTD | -4.54% |
| Year | +3.67% |
| 10 Years | -5.71% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $75.43 | 2,337,100 |
| 2026-06-17 | $74.56 | 1,433,600 |
| 2026-06-16 | $76.56 | 1,344,700 |
| 2026-06-15 | $76.90 | 1,400,000 |
| 2026-06-12 | $78.87 | 1,124,600 |
| 2026-06-11 | $79.22 | 1,450,000 |
| 2026-06-10 | $80.94 | 1,318,000 |
| 2026-06-09 | $82.46 | 1,813,900 |
| 2026-06-08 | $78.76 | 2,048,600 |
| 2026-06-05 | $81.01 | 1,726,900 |
| 2026-06-04 | $82.42 | 2,488,600 |
| 2026-06-03 | $78.36 | 1,793,400 |
| 2026-06-02 | $76.43 | 2,374,100 |
| 2026-06-01 | $75.84 | 2,350,900 |
| 2026-05-29 | $74.95 | 12,832,500 |
| 2026-05-28 | $75.94 | 1,591,100 |
| 2026-05-27 | $75.89 | 2,767,600 |
| 2026-05-26 | $76.27 | 1,068,800 |
| 2026-05-22 | $76.83 | 1,629,300 |
| 2026-05-21 | $76.75 | 1,216,900 |
| 2026-05-20 | $76.13 | 1,348,000 |
| 2026-05-19 | $74.73 | 1,350,100 |
About Solventum Corporation
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.
đ° Latest News
Cooper Companies Stock: Is COO Underperforming the Healthcare Sector?
Barchart âĸ 2026-06-16T12:07:27Z
Solventum (SOLV) Stock Valuation Gap Examined After Recent Momentum Gains
Simply Wall St. âĸ 2026-06-13T10:10:07Z
Solventum (SOLV) Stock Sees Split Analyst Revisions After Post Spin Margin Debate
Simply Wall St. âĸ 2026-06-13T00:14:48Z
Is Solventum Corporation (SOLV) A Good Stock To Buy Now?
Insider Monkey âĸ 2026-06-11T20:13:16Z
1 Profitable Stock with Exciting Potential and 2 That Underwhelm
StockStory âĸ 2026-06-09T09:02:14Z
Solventum Trends for 2026: AI Coding, Tariffs, and Margins
Zacks âĸ 2026-06-08T17:32:00Z
Q1 Earnings Roundup: Solventum (NYSE:SOLV) And The Rest Of The Surgical Equipment & Consumables - Diversified Segment
StockStory âĸ 2026-06-08T08:29:50Z
Is Solventumâs (SOLV) Governance Tweaks Hinting At How It Will Navigate AI Disruption?
Simply Wall St. âĸ 2026-06-08T00:15:32Z
Cencora (COR) Up 5.7% Since Last Earnings Report: Can It Continue?
Zacks âĸ 2026-06-05T15:30:12Z
Solventum Corporation (SOLV) Fell as Its HCIT Unit Hurt by AI Disruption Fears
Insider Monkey âĸ 2026-06-04T13:17:03Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $3,874,000,000 | $3,661,000,000 | $3,504,000,000 | $3,435,000,000 |
| Cost Of Revenue | $3,874,000,000 | $3,661,000,000 | $3,504,000,000 | $3,435,000,000 |
| Total Revenue | $8,325,000,000 | $8,254,000,000 | $8,197,000,000 | $8,130,000,000 |
| Operating Revenue | $8,325,000,000 | $8,254,000,000 | $8,197,000,000 | $8,130,000,000 |
| Expenses | ||||
| Interest Expense | $347,000,000 | $367,000,000 | $0 | $0 |
| Total Expenses | $7,693,000,000 | $7,218,000,000 | $6,561,000,000 | $6,437,000,000 |
| Other Income Expense | $1,428,000,000 | $-64,000,000 | $31,000,000 | $-1,000,000 |
| Other Non Operating Income Expenses | $-39,000,000 | $-64,000,000 | $-25,000,000 | $-1,000,000 |
| Net Non Operating Interest Income Expense | $-347,000,000 | $-367,000,000 | $0 | $0 |
| Interest Expense Non Operating | $347,000,000 | $367,000,000 | $0 | $0 |
| Operating Expense | $3,819,000,000 | $3,557,000,000 | $3,057,000,000 | $3,002,000,000 |
| Rent Expense Supplemental | - | - | $481,000,000 | $482,000,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $1,556,000,000 | $479,000,000 | $1,346,000,000 | $1,343,000,000 |
| Net Interest Income | $-347,000,000 | $-367,000,000 | $0 | $0 |
| Normalized Income | $223,453,590 | $479,000,000 | $1,300,808,000 | $1,343,000,000 |
| Net Income From Continuing And Discontinued Operation | $1,556,000,000 | $479,000,000 | $1,346,000,000 | $1,343,000,000 |
| Total Operating Income As Reported | $2,181,000,000 | $1,036,000,000 | $1,692,000,000 | $1,693,000,000 |
| Net Income Common Stockholders | $1,556,000,000 | $479,000,000 | $1,346,000,000 | $1,343,000,000 |
| Net Income | $1,556,000,000 | $479,000,000 | $1,346,000,000 | $1,343,000,000 |
| Net Income Including Noncontrolling Interests | $1,556,000,000 | $478,000,000 | $1,346,000,000 | $1,343,000,000 |
| Net Income Continuous Operations | $1,556,000,000 | $478,000,000 | $1,346,000,000 | $1,343,000,000 |
| Pretax Income | $1,713,000,000 | $605,000,000 | $1,667,000,000 | $1,692,000,000 |
| Special Income Charges | $1,467,000,000 | $0 | $56,000,000 | - |
| Operating Income | $632,000,000 | $1,036,000,000 | $1,636,000,000 | $1,693,000,000 |
| Gross Profit | $4,451,000,000 | $4,593,000,000 | $4,693,000,000 | $4,695,000,000 |
| Per Share | ||||
| Diluted EPS | $8.88 | $2.76 | $7.79 | $7.78 |
| Basic EPS | $8.94 | $2.77 | $7.79 | $7.78 |
| Other | ||||
| Tax Effect Of Unusual Items | $134,453,590 | $0 | $10,808,000 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $1,082,000,000 | $1,527,000,000 | $2,172,000,000 | $2,270,000,000 |
| Total Unusual Items | $1,467,000,000 | $0 | $56,000,000 | - |
| Total Unusual Items Excluding Goodwill | $1,467,000,000 | $0 | $56,000,000 | - |
| Reconciled Depreciation | $489,000,000 | $555,000,000 | $561,000,000 | $578,000,000 |
| EBITDA (Bullshit earnings) | $2,549,000,000 | $1,527,000,000 | $2,228,000,000 | $2,270,000,000 |
| EBIT | $2,060,000,000 | $972,000,000 | $1,667,000,000 | $1,692,000,000 |
| Diluted Average Shares | $175,300,000 | $173,700,000 | $172,709,175 | $172,700,000 |
| Basic Average Shares | $174,100,000 | $173,200,000 | $172,709,175 | $172,700,000 |
| Diluted NI Availto Com Stockholders | $1,556,000,000 | $479,000,000 | $1,346,000,000 | $1,343,000,000 |
| Tax Provision | $157,000,000 | $127,000,000 | $321,000,000 | $349,000,000 |
| Gain On Sale Of Business | $1,549,000,000 | $0 | $56,000,000 | - |
| Other Special Charges | $82,000,000 | - | - | - |
| Research And Development | $739,000,000 | $775,000,000 | $758,000,000 | $767,000,000 |
| Selling General And Administration | $3,080,000,000 | $2,782,000,000 | $2,299,000,000 | $2,235,000,000 |
Fetched: 2026-06-17
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-3,246,000,000 | $-5,962,000,000 | $2,229,000,000 | $2,056,000,000 |
| Total Assets | $14,294,000,000 | $14,457,000,000 | $13,943,000,000 | $13,594,000,000 |
| Total Non Current Assets | $10,436,000,000 | $11,208,000,000 | $11,424,000,000 | $11,363,000,000 |
| Other Non Current Assets | $814,000,000 | $665,000,000 | $530,000,000 | $358,000,000 |
| Goodwill And Other Intangible Assets | $8,296,000,000 | $8,921,000,000 | $9,437,000,000 | $9,686,000,000 |
| Other Intangible Assets | $2,592,000,000 | $2,544,000,000 | $2,902,000,000 | $3,252,000,000 |
| Current Assets | $3,859,000,000 | $3,249,000,000 | $2,519,000,000 | $2,231,000,000 |
| Other Current Assets | $557,000,000 | $120,000,000 | $155,000,000 | $126,000,000 |
| Prepaid Assets | $174,000,000 | $173,000,000 | - | - |
| Inventory | $1,066,000,000 | $965,000,000 | $857,000,000 | $873,000,000 |
| Receivables | $1,184,000,000 | $1,229,000,000 | $1,313,000,000 | $1,171,000,000 |
| Accounts Receivable | $1,034,000,000 | $1,044,000,000 | $1,313,000,000 | $1,171,000,000 |
| Allowance For Doubtful Accounts Receivable | $-87,000,000 | $-86,000,000 | $-82,000,000 | - |
| Gross Accounts Receivable | $1,121,000,000 | $1,130,000,000 | $1,395,000,000 | - |
| Cash Cash Equivalents And Short Term Investments | $878,000,000 | $762,000,000 | $194,000,000 | $61,000,000 |
| Cash And Cash Equivalents | $878,000,000 | $762,000,000 | $194,000,000 | $61,000,000 |
| Debt | ||||
| Net Debt | $4,157,000,000 | $7,248,000,000 | $7,703,000,000 | - |
| Total Debt | $5,035,000,000 | $8,010,000,000 | $8,303,000,000 | - |
| Long Term Debt And Capital Lease Obligation | $5,035,000,000 | $7,810,000,000 | $8,303,000,000 | - |
| Long Term Debt | $5,035,000,000 | $7,810,000,000 | $8,303,000,000 | - |
| Current Debt And Capital Lease Obligation | - | $200,000,000 | - | - |
| Current Debt | - | $200,000,000 | - | - |
| Other Current Borrowings | - | $200,000,000 | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $9,244,000,000 | $11,498,000,000 | $2,277,000,000 | $1,852,000,000 |
| Total Non Current Liabilities Net Minority Interest | $6,108,000,000 | $8,795,000,000 | $549,000,000 | $541,000,000 |
| Other Non Current Liabilities | $546,000,000 | $410,000,000 | $152,000,000 | $235,000,000 |
| Non Current Deferred Liabilities | $164,000,000 | $225,000,000 | $231,000,000 | $215,000,000 |
| Non Current Deferred Taxes Liabilities | $164,000,000 | $225,000,000 | $231,000,000 | $215,000,000 |
| Current Liabilities | $3,136,000,000 | $2,703,000,000 | $1,728,000,000 | $1,311,000,000 |
| Other Current Liabilities | $634,000,000 | $378,000,000 | $156,000,000 | $171,000,000 |
| Current Deferred Liabilities | $621,000,000 | $572,000,000 | $574,000,000 | $559,000,000 |
| Payables And Accrued Expenses | $1,561,000,000 | $1,272,000,000 | $789,000,000 | $516,000,000 |
| Interest Payable | $71,000,000 | $114,000,000 | $0 | - |
| Payables | $1,318,000,000 | $1,012,000,000 | $583,000,000 | $348,000,000 |
| Total Tax Payable | $196,000,000 | $122,000,000 | $106,000,000 | - |
| Accounts Payable | $687,000,000 | $618,000,000 | $477,000,000 | $348,000,000 |
| Minimum Pension Liabilities | - | - | - | $7,000,000 |
| Equity | ||||
| Common Stock Equity | $5,050,000,000 | $2,959,000,000 | $11,666,000,000 | $11,742,000,000 |
| Total Equity Gross Minority Interest | $5,050,000,000 | $2,959,000,000 | $11,666,000,000 | $11,742,000,000 |
| Stockholders Equity | $5,050,000,000 | $2,959,000,000 | $11,666,000,000 | $11,742,000,000 |
| Gains Losses Not Affecting Retained Earnings | $-625,000,000 | $-1,056,000,000 | $-337,000,000 | $-497,000,000 |
| Other Equity Adjustments | $-625,000,000 | $-1,056,000,000 | $-337,000,000 | - |
| Retained Earnings | $1,797,000,000 | $242,000,000 | $0 | - |
| Other Equity Interest | - | - | $12,003,000,000 | $12,239,000,000 |
| Other | ||||
| Ordinary Shares Number | $173,490,864 | $172,785,606 | $172,709,175 | $172,709,175 |
| Share Issued | $173,490,864 | $172,785,606 | $172,709,175 | $172,709,175 |
| Tangible Book Value | $-3,246,000,000 | $-5,962,000,000 | $2,229,000,000 | $2,056,000,000 |
| Invested Capital | $10,085,000,000 | $10,969,000,000 | $11,666,000,000 | $11,742,000,000 |
| Working Capital | $723,000,000 | $546,000,000 | $791,000,000 | $920,000,000 |
| Total Capitalization | $10,085,000,000 | $10,769,000,000 | $11,666,000,000 | $11,742,000,000 |
| Additional Paid In Capital | $3,876,000,000 | $3,771,000,000 | $0 | - |
| Capital Stock | $2,000,000 | $2,000,000 | $0 | - |
| Common Stock | $2,000,000 | $2,000,000 | $0 | - |
| Employee Benefits | $363,000,000 | $350,000,000 | $166,000,000 | $91,000,000 |
| Non Current Pension And Other Postretirement Benefit Plans | $363,000,000 | $350,000,000 | $166,000,000 | $91,000,000 |
| Current Deferred Revenue | $621,000,000 | $572,000,000 | $574,000,000 | $559,000,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $320,000,000 | $281,000,000 | $209,000,000 | $65,000,000 |
| Current Accrued Expenses | $243,000,000 | $260,000,000 | $206,000,000 | $168,000,000 |
| Dueto Related Parties Current | $435,000,000 | $272,000,000 | $0 | - |
| Goodwill | $5,704,000,000 | $6,377,000,000 | $6,535,000,000 | $6,434,000,000 |
| Net PPE | $1,326,000,000 | $1,622,000,000 | $1,457,000,000 | $1,319,000,000 |
| Accumulated Depreciation | $-1,867,000,000 | $-1,988,000,000 | $-1,881,000,000 | $-1,771,000,000 |
| Gross PPE | $3,193,000,000 | $3,610,000,000 | $3,338,000,000 | $3,090,000,000 |
| Construction In Progress | $499,000,000 | $504,000,000 | $320,000,000 | $240,000,000 |
| Machinery Furniture Equipment | $1,824,000,000 | $2,150,000,000 | $2,081,000,000 | $1,965,000,000 |
| Buildings And Improvements | $870,000,000 | $956,000,000 | $937,000,000 | $856,000,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $636,000,000 | $539,000,000 | $453,000,000 | $468,000,000 |
| Work In Process | $201,000,000 | $190,000,000 | $171,000,000 | $173,000,000 |
| Raw Materials | $229,000,000 | $236,000,000 | $233,000,000 | $232,000,000 |
| Duefrom Related Parties Current | $150,000,000 | $185,000,000 | $0 | - |
| Other Properties | - | - | $1,466,000,000 | $29,000,000 |
| Foreign Currency Translation Adjustments | - | - | - | $-504,000,000 |
Fetched: 2026-06-17
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-10,000,000 | $805,000,000 | $1,625,000,000 | $1,428,000,000 |
| Operating Activities | ||||
| Operating Cash Flow | $369,000,000 | $1,185,000,000 | $1,915,000,000 | $1,679,000,000 |
| Cash Flow From Continuing Operating Activities | $369,000,000 | $1,185,000,000 | $1,915,000,000 | $1,679,000,000 |
| Operating Gains Losses | $-1,487,000,000 | $34,000,000 | $-15,000,000 | $64,000,000 |
| Investing Activities | ||||
| Capital Expenditure | $-379,000,000 | $-380,000,000 | $-290,000,000 | $-251,000,000 |
| Investing Cash Flow | $2,797,000,000 | $-380,000,000 | $-230,000,000 | $-253,000,000 |
| Cash Flow From Continuing Investing Activities | $2,797,000,000 | $-380,000,000 | $-230,000,000 | $-253,000,000 |
| Net Other Investing Changes | $-18,000,000 | - | - | $-2,000,000 |
| Financing Activities | ||||
| Financing Cash Flow | $-3,057,000,000 | $-240,000,000 | $-1,552,000,000 | $-1,460,000,000 |
| Cash Flow From Continuing Financing Activities | $-3,057,000,000 | $-240,000,000 | $-1,552,000,000 | $-1,460,000,000 |
| Net Other Financing Charges | $13,000,000 | $-8,243,000,000 | $-1,552,000,000 | $-1,460,000,000 |
| Other | ||||
| Repayment Of Debt | $-3,070,000,000 | $-300,000,000 | $0 | $0 |
| Issuance Of Debt | $0 | $8,303,000,000 | $0 | $0 |
| Interest Paid Supplemental Data | $181,000,000 | $287,000,000 | $0 | $0 |
| Income Tax Paid Supplemental Data | $181,000,000 | $244,000,000 | $0 | $0 |
| End Cash Position | $878,000,000 | $762,000,000 | $194,000,000 | $61,000,000 |
| Beginning Cash Position | $762,000,000 | $194,000,000 | $61,000,000 | $91,000,000 |
| Effect Of Exchange Rate Changes | $7,000,000 | $3,000,000 | $0 | $4,000,000 |
| Changes In Cash | $109,000,000 | $565,000,000 | $133,000,000 | $-34,000,000 |
| Net Issuance Payments Of Debt | $-3,070,000,000 | $8,003,000,000 | $0 | $0 |
| Net Long Term Debt Issuance | $-3,070,000,000 | $8,003,000,000 | $0 | $0 |
| Long Term Debt Payments | $-3,070,000,000 | $-300,000,000 | $0 | $0 |
| Long Term Debt Issuance | $0 | $8,303,000,000 | $0 | $0 |
| Net Business Purchase And Sale | $3,194,000,000 | $0 | $60,000,000 | $0 |
| Sale Of Business | $3,890,000,000 | $0 | $60,000,000 | $0 |
| Purchase Of Business | $-696,000,000 | $0 | $0 | - |
| Net PPE Purchase And Sale | $-379,000,000 | $-380,000,000 | $-290,000,000 | $-251,000,000 |
| Purchase Of PPE | $-379,000,000 | $-380,000,000 | $-290,000,000 | $-251,000,000 |
| Change In Working Capital | $-119,000,000 | $160,000,000 | $126,000,000 | $-202,000,000 |
| Change In Other Working Capital | $-194,000,000 | $67,000,000 | $-15,000,000 | $-113,000,000 |
| Change In Payables And Accrued Expense | $136,000,000 | $-51,000,000 | $247,000,000 | $25,000,000 |
| Change In Accrued Expense | $43,000,000 | $78,000,000 | $142,000,000 | - |
| Change In Payable | $93,000,000 | $-129,000,000 | $105,000,000 | $25,000,000 |
| Change In Account Payable | $104,000,000 | $266,000,000 | $105,000,000 | $25,000,000 |
| Change In Inventory | $-139,000,000 | $-132,000,000 | $23,000,000 | $-82,000,000 |
| Change In Receivables | $78,000,000 | $276,000,000 | $-129,000,000 | $-32,000,000 |
| Changes In Account Receivables | $34,000,000 | $43,000,000 | $-129,000,000 | $-32,000,000 |
| Other Non Cash Items | $-111,000,000 | - | - | - |
| Stock Based Compensation | $161,000,000 | $112,000,000 | $39,000,000 | $37,000,000 |
| Deferred Tax | $-120,000,000 | $-155,000,000 | $-142,000,000 | $-141,000,000 |
| Deferred Income Tax | $-120,000,000 | $-155,000,000 | $-142,000,000 | $-141,000,000 |
| Depreciation Amortization Depletion | $489,000,000 | $555,000,000 | $561,000,000 | $578,000,000 |
| Depreciation And Amortization | $489,000,000 | $555,000,000 | $561,000,000 | $578,000,000 |
| Pension And Employee Benefit Expense | $62,000,000 | $34,000,000 | $41,000,000 | $64,000,000 |
| Gain Loss On Sale Of Business | $-1,549,000,000 | $0 | $-56,000,000 | $0 |
| Net Income From Continuing Operations | $1,556,000,000 | $479,000,000 | $1,346,000,000 | $1,343,000,000 |
| Change In Other Current Liabilities | - | - | $137,000,000 | $-101,000,000 |
| Net Investment Purchase And Sale | - | - | - | $0 |
| Sale Of Investment | - | - | - | $0 |
Fetched: 2026-06-17